Protective Role of Inhaled Steroids for Covid-19 Infection
Status:
Terminated
Trial end date:
2021-05-28
Target enrollment:
Participant gender:
Summary
We hypothesize that inhaled steroid therapy and long acting beta 2 adrenergic agonist, widely
prescribed in asthma patients, may also have a local protective effect against coronavirus
infection, even in patients without asthma.
The primary purpose is To compare time to clinical improvement in patients receiving standard
of care associated to the combination budesonide/formoterol or standard of care only.
Time (in days) to clinical improvement is defined as the time from randomization to an
improvement of two points (from the status at randomization) on a seven-category ordinal
scale or live discharge from the hospital, whichever came first within 30 days.